# FDA Inspection 808143 - Biomat Usa Inc - November 16, 2012

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/c9df16d0-5a91-4e42-be43-79da8d94b4ed
Source feed: FDA_Inspections

> FDA Inspection 808143 for Biomat Usa Inc on November 16, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 808143
- Company Name: Biomat Usa Inc
- Inspection Date: 2012-11-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1099753 - 2019-07-19](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/45317270-7f66-4aa6-b71c-c5eb09a27e6a)
- [FDA Inspection 927282 - 2015-04-10](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/83984679-cf3b-4337-869d-2490f0a97fe6)
- [FDA Inspection 598426 - 2009-07-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/2cab5e14-d499-4790-b6f4-5344158e951d)

Company: https://www.keypedia.com/companies/biomat-usa-inc/27077afb-6585-471a-8d89-1aef5254420d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d